Track Real Time Price

According to ChemAnalyst , The Guaifenesin Prices recorded a firm upward movement during the second quarter of 2026, with logistics and freight expenses emerging as important contributors to higher delivered costs across major consuming regions. Guaifenesin, an expectorant widely used in over-the-counter cough and cold formulations, is an established pharmaceutical ingredient with demand closely linked to pharmaceutical manufacturing, seasonal respiratory-care requirements, and the production of finished-dose medicines. During Q2 2026, the global guaifenesin market experienced noticeable cost pressure as freight rates, insurance expenses, container availability, and transit conditions affected international trade flows. While the underlying manufacturing economics remained relatively stable compared with logistics-related factors, higher transportation expenses translated into increased landed costs for buyers. In North America, the United States recorded a 7.719% quarter-over-quarter...